Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 13270
TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509812(CHEMBL4548532 | US20250289848, Example 57)
Affinity DataKi:  440nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509813(CHEMBL4451478 | US20250289848, Example 53)
Affinity DataKi:  640nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509810(CHEMBL4464142 | US20250289848, Example 52)
Affinity DataKi:  1.50E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509781(CHEMBL4450852 | US20250289848, Example 34)
Affinity DataKi:  1.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509801(CHEMBL4464433 | US20250289848, Example 30)
Affinity DataKi:  1.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509803(CHEMBL4449577 | US20250289848, Example 35)
Affinity DataKi:  2.20E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509802(CHEMBL4515157 | US20250289848, Example 31)
Affinity DataKi:  2.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509818(CHEMBL4579221 | US20250289848, Example 33)
Affinity DataKi:  2.40E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509819(CHEMBL4460073 | US20250289848, Example 38)
Affinity DataKi:  2.50E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509817(CHEMBL4565782 | US20250289848, Example 32)
Affinity DataKi:  2.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509804(CHEMBL4455488 | US20250289848, Example 37)
Affinity DataKi:  2.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509799(CHEMBL4532791 | US20250289848, Example 27)
Affinity DataKi:  2.70E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509807(CHEMBL4560197 | US20250289848, Example 46)
Affinity DataKi:  2.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509829(CHEMBL4456139 | US20250289848, Example 28)
Affinity DataKi:  3.10E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509833(CHEMBL4464915 | US20250289848, Example 36)
Affinity DataKi:  3.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509796(CHEMBL4535419 | US20250289848, Example 21)
Affinity DataKi:  3.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509780(CHEMBL4538548 | US20250289848, Example 25)
Affinity DataKi:  3.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509798(CHEMBL4515538 | US20250289848, Example 26)
Affinity DataKi:  3.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509805(CHEMBL4451874 | US20250289848, Example 40)
Affinity DataKi:  3.70E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509823(CHEMBL4561695 | US20250289848, Example 55)
Affinity DataKi:  3.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509827(CHEMBL4544508 | US20250289848, Example 19)
Affinity DataKi:  4.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509828(CHEMBL4591545 | US20250289848, Example 24)
Affinity DataKi:  4.50E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509786(CHEMBL4577989 | US20250289848, Example 54)
Affinity DataKi:  4.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509811(CHEMBL4465565 | US20250289848, Example 56)
Affinity DataKi:  5.20E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509822(CHEMBL4590084 | US20250289848, Example 48)
Affinity DataKi:  6.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509809(CHEMBL4483303 | US20250289848, Example 50)
Affinity DataKi:  6.70E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509831(CHEMBL4446715 | US20250289848, Example 22)
Affinity DataKi:  7.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509830(CHEMBL4437760 | US20250289848, Example 49)
Affinity DataKi:  8.00E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509795(CHEMBL4437433 | US20250289848, Example 20)
Affinity DataKi:  8.50E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509797(CHEMBL4471868 | US20250289848, Example 23)
Affinity DataKi:  8.90E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509785(CHEMBL4471027 | US20250289848, Example 43)
Affinity DataKi:  9.30E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509800(CHEMBL4561875 | US20250289848, Example 29)
Affinity DataKi:  9.60E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509794(CHEMBL4452305 | US20250289848, Example 18)
Affinity DataKi:  9.70E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509808(CHEMBL4583661 | US20250289848, Example 47)
Affinity DataKi:  1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509778(CHEMBL4584378 | US20250289848, Example 51)
Affinity DataKi:  1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509806(CHEMBL4552917 | US20250289848, Example 41)
Affinity DataKi:  1.10E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509815(CHEMBL4468897 | US20250289848, Example 9)
Affinity DataKi:  1.10E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509793(CHEMBL4590503 | US20250289848, Example 16)
Affinity DataKi:  1.20E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509777(CHEMBL4440977 | US20250289848, Example 42)
Affinity DataKi:  1.40E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509826(CHEMBL4552947 | US20250289848, Example 10)
Affinity DataKi:  1.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509792(CHEMBL4463747 | US20250289848, Example 13)
Affinity DataKi:  1.60E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509779(CHEMBL4451526 | US20250289848, Example 17)
Affinity DataKi:  1.70E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509821(CHEMBL4456175 | US20250289848, Example 44)
Affinity DataKi:  2.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509832(CHEMBL4442839 | US20250289848, Example 45)
Affinity DataKi:  2.50E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509820(CHEMBL4438567 | US20250289848, Example 39)
Affinity DataKi:  7.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509784(CHEMBL4449274 | US20250289848, Example 12)
Affinity DataKi:  8.90E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509791(CHEMBL4542718 | US20250289848, Example 11)
Affinity DataKi:  8.90E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509816(CHEMBL4582542 | US20250289848, Example 15)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCatenin beta-1 (138-781), Transcription Factor 4 (7-51), and Cadherin-1 (819-873)(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM50509783(CHEMBL4451028 | US20250289848, Example 14)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent